<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <!-- Generated by Workiva -->
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002020969</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001601830</issuerCik>
      <issuerName>Recursion Pharmaceuticals, Inc.</issuerName>
      <secFileNumber>001-40323</secFileNumber>
      <issuerAddress>
        <com:street1>41 S Rio Grande Street</com:street1>
        <com:city>Salt Lake City</com:city>
        <com:stateOrCountry>UT</com:stateOrCountry>
        <com:zipCode>84101</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>385-269-0203</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Najat Khan</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Merrill Lynch</name>
        <address>
          <com:street1>301 Tresser Blvd.</com:street1>
          <com:city>Stamford</com:city>
          <com:stateOrCountry>CT</com:stateOrCountry>
          <com:zipCode>06901</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>124403</noOfUnitsSold>
      <aggregateMarketValue>548587.96</aggregateMarketValue>
      <noOfUnitsOutstanding>514895802</noOfUnitsOutstanding>
      <approxSaleDate>12/22/2025</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>11/15/2025</acquiredDate>
      <natureOfAcquisitionTransaction>Equity Compensation</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Recursion Pharmaceuticals</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>23946</amountOfSecuritiesAcquired>
      <paymentDate>11/15/2025</paymentDate>
      <natureOfPayment>Equity Compensation</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>08/15/2025</acquiredDate>
      <natureOfAcquisitionTransaction>Equity Compensation</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Recursion Pharmaceuticals</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>91121</amountOfSecuritiesAcquired>
      <paymentDate>08/15/2025</paymentDate>
      <natureOfPayment>Equity Compensation</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>05/15/2025</acquiredDate>
      <natureOfAcquisitionTransaction>Equity Compensation</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Recursion Pharmaceuticals</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>9336</amountOfSecuritiesAcquired>
      <paymentDate>05/15/2025</paymentDate>
      <natureOfPayment>Equity Compensation</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>12/22/2025</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>09/22/2025</planAdoptionDate>
      </planAdoptionDates>
      <signature>Najat Khan</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
